Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
about
A potential role of alternative splicing in the regulation of the transcriptional activity of human GLI2 in gonadal tissues.Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathwayCD200-expressing human basal cell carcinoma cells initiate tumor growthGLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cellsDisruption of Vitamin D and Calcium Signaling in Keratinocytes Predisposes to Skin CancerSignal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their CrosstalksHedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cellsPlatform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral DecompositionCross-platform expression profiling demonstrates that SV40 small tumor antigen activates Notch, Hedgehog, and Wnt signaling in human cellsLoss of pericyte smoothened activity in mice with genetic deficiency of leptin.The vitamin D receptor: a tumor suppressor in skin.Vitamin D and the skin: Physiology and pathophysiology.Arhgap36-dependent activation of Gli transcription factors.Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.Protective actions of vitamin D in UVB induced skin cancer.Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.Protective role of vitamin D signaling in skin cancer formation.Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cellsSignificance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway.Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cellsThe protective role of vitamin d signaling in non-melanoma skin cancer.Blocking signaling at the level of GLI regulates downstream gene expression and inhibits proliferation of canine osteosarcoma cellsOdontogenic keratocysts arise from quiescent epithelial rests and are associated with deregulated hedgehog signaling in mice and humansOverexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null miceInhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cellsSOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines.Evaluation of WO2014207069 A1: Multitarget Hedgehog pathway inhibitors and uses thereof.Expression analysis of multiple myeloma CD138 negative progenitor cells using single molecule microarray readout.PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients.FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathwaySmall-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockadeAberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar-ductal metaplasia.Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signalingMechanisms of Hedgehog signalling in cancer.Canonical and non-canonical Hedgehog signalling and the control of metabolism.Vitamin D receptor, a tumor suppressor in skin.
P2860
Q24309518-FB1BE5B9-F389-4D35-9F25-D329FD005A91Q24623800-99B37230-F41F-485F-BE38-A5FAFD6BD4D7Q24630272-836D228F-FB3A-4DD8-8FFA-02435826FE8FQ24653046-A792C510-06EA-4A46-90D8-7F238130A4B8Q26741417-00AB493E-86EE-4359-8B4A-143F8E2E7051Q26752554-37859010-DD35-46EA-BD29-EDA1D5F0B8FDQ28246460-7AAFFF86-CD32-4407-8AF2-3A8716620DE5Q29300552-AF105607-6D87-4161-9B63-3C7737E4D65DQ33235713-9128B6E6-CD02-473B-84EC-2C6E0F3AA6C0Q33587672-B3EC6DDB-B27D-4278-B3B1-EA3BCE3173FAQ33806485-43CFCE29-505B-4E11-A34B-57F56A6378AEQ33993788-4FEC929A-E875-46A9-8F08-7415C9C401ECQ34002623-794D8E44-B794-4E3A-9DAE-86A792908A5AQ34244929-1D97BFBB-2B62-4AB8-A214-99D9A12AF4F5Q34418244-877C0FD7-2CB2-4097-816C-4FFB6A27561EQ34426872-12B974DA-C670-4263-9CCD-14E8AED790ABQ34443888-0F3F97F4-CE75-4180-B08B-14B018C7DB89Q34561698-310960E1-2EE5-4DB0-ACF4-59E2B1136398Q34995035-5914FE41-762A-4E99-856E-E55AB3E5C4F9Q35000293-1DD3AD3B-4636-47A4-92F8-9167343E0477Q35005479-91618EB5-CFA8-49F4-8FDF-F3E6E0E94325Q35033717-F19F0141-73D0-437C-8A25-60E6F92919E4Q35165531-47AEDA3B-DD37-4312-9D27-BCC6FDCF207DQ35222019-09F1C04C-8468-4D7F-BA30-4F0CF76B23EDQ35349544-6B556DD4-F35E-4070-85E4-4C3B356B8E17Q35785923-57B80F52-B671-4CA7-8774-4C8B87827C30Q35835273-DC0EBD86-A273-48C2-B2AC-B26149986833Q35847295-299585C8-2423-4CDB-9E66-C78D8BB901DEQ35868567-18F061EB-87F9-4968-8832-3BBA3666674DQ36785501-AA677833-6791-472D-9D46-E19277E678EAQ36944052-71D2820D-E4D9-45F4-BFDA-7DB5A020D872Q37046814-BA580F0D-98C6-4FC1-9C99-EC64F6C6DC4CQ37249645-8B6944B5-9C3C-4114-A1DC-6BB06F3D5E72Q37291730-D8B42CE2-A93B-4B87-BA3F-46ACC5354265Q37295628-5DB4033D-71AD-4966-9EAF-6F866DB64787Q37343012-DF6332A3-3884-438E-BE9F-6F10DC26A542Q37487211-74970CA3-A02F-42DC-878B-15481984A467Q37923514-698C1124-9689-4A98-B951-151CD0858C78Q38215035-17292E31-2AE1-47CE-BDC0-ED0F50D44DCDQ38307555-138DC0D1-A915-4E6C-BD8E-8DDB1AC08EE0
P2860
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@ast
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@en
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@en-gb
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@nl
type
label
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@ast
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@en
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@en-gb
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@nl
prefLabel
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@ast
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@en
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@en-gb
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
@en
P2093
Anna-Maria Frischauf
Anthony G Quinn
Fritz Aberger
Gerhard Regl
Graham W Neill
Helmut Hintner
Josef Koller
Maria Kasper
Mohammed S Ikram
Thomas Eichberger
P2860
P2888
P304
P3181
P356
10.1038/SJ.ONC.1205748
P407
P577
2002-08-15T00:00:00Z
P5875
P6179
1022720510